DMPP is a well-known nicotinic agonist that does not fit any proposed pharmacophore for nicotinic binding and represents a unique ligand among the hundreds of nicotinic agonists studied in the past decades. A systematic modulation of the chemical structure of DMPP, aimed to establish its structure-affinity relationships, is reported. The research has allowed to identify molecules such as 11c, 13c, 14c, and 28c, with affinities for R4â2 receptors in the low nanomolar range, some 2 orders of magnitude lower than the lead compound. The agonistic properties of the most interesting compounds have been assessed by measuring their analgesic activity on mice (hot-plate test). Another result of the research was the identification of DMPP analogues, such as 3a (Ki ) 90 nM) and 14b (Ki ) 180 nM), that maintain affinity for the central nicotinic receptor when the ammonium function is changed into an aminic one and are therefore possible leads for drug development in neurodegenerative diseases.
Structure-affinity relationships of a unique nicotinic ligand: N1-dimethyl-N4-phenylpiperazinium iodide (DMPP) / Romanelli, MARIA NOVELLA; Manetti, Dina; Scapecchi, Serena; Borea, P.; Dei, Silvia; Bartolini, Alessandro; Ghelardini, Carla; Gualtieri, Fulvio; Guandalini, Luca; Varani, K.. - In: JOURNAL OF MEDICINAL CHEMISTRY. - ISSN 0022-2623. - STAMPA. - 44:(2001), pp. 3946-3955. [10.1021/jm010901y]
Structure-affinity relationships of a unique nicotinic ligand: N1-dimethyl-N4-phenylpiperazinium iodide (DMPP)
ROMANELLI, MARIA NOVELLA;MANETTI, DINA;SCAPECCHI, SERENA;DEI, SILVIA;BARTOLINI, ALESSANDRO;GHELARDINI, CARLA;GUALTIERI, FULVIO;GUANDALINI, LUCA;
2001
Abstract
DMPP is a well-known nicotinic agonist that does not fit any proposed pharmacophore for nicotinic binding and represents a unique ligand among the hundreds of nicotinic agonists studied in the past decades. A systematic modulation of the chemical structure of DMPP, aimed to establish its structure-affinity relationships, is reported. The research has allowed to identify molecules such as 11c, 13c, 14c, and 28c, with affinities for R4â2 receptors in the low nanomolar range, some 2 orders of magnitude lower than the lead compound. The agonistic properties of the most interesting compounds have been assessed by measuring their analgesic activity on mice (hot-plate test). Another result of the research was the identification of DMPP analogues, such as 3a (Ki ) 90 nM) and 14b (Ki ) 180 nM), that maintain affinity for the central nicotinic receptor when the ammonium function is changed into an aminic one and are therefore possible leads for drug development in neurodegenerative diseases.File | Dimensione | Formato | |
---|---|---|---|
jmc_DMPP_01.pdf
Accesso chiuso
Descrizione: articolo
Tipologia:
Pdf editoriale (Version of record)
Licenza:
DRM non definito
Dimensione
125.16 kB
Formato
Adobe PDF
|
125.16 kB | Adobe PDF | Richiedi una copia |
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.